DroneShield's A$240 Million Backlog Sets Up a Clash Between Institutional Conviction and Short-Seller Pressure

DroneShield's A$240M backlog and RfRecon launch face heavy short selling, as Citigroup and JPMorgan build stakes, keeping shares volatile.

The battle over DroneShield's future is playing out in plain sight, with two of Wall Street's biggest names building positions in the counter-drone specialist while short sellers have simultaneously made it one of the most heavily bet-against stocks on the Australian exchange. That unusual convergence of opposing forces has left the shares trading in a narrow band, with the company's freshly confirmed order book doing little to settle the debate.

DroneShield had secured committed revenue of A$240 million as of August 21, with A$43 million of that total tied to deliveries scheduled for fiscal 2027 and beyond. The visibility extends well past the current year, giving management a clearer runway than the company has typically enjoyed. The figure underpins the reiterated full-year guidance of A$250 million to A$270 million in revenue for fiscal 2026, which was reaffirmed alongside the half-year results released last week.

The stock has been drifting since that print, trading at €1.11 on Monday with a 2.2 percent gain, though it remains roughly 15 percent below its 50-day moving average. That technical weakness reflects a broader pattern: the shares have shed around 40 percent since the start of the year, even as the operational story has improved.

Recurring Revenue Shifts the Model

The composition of that backlog points to a business in transition. Recurring revenue jumped to A$11.5 million in the first half of fiscal 2026, up from roughly A$3.5 million in the prior-year period, lifting its share of total revenue to 9.2 percent. For a company long dependent on one-off orders, the growing base of predictable income is a structural shift that should, in theory, support a more stable valuation over time.

The backlog itself reinforces that narrative. A meaningful portion is already contracted for periods beyond the current fiscal year, suggesting customers are committing to longer-term arrangements rather than placing spot orders. That evolution in customer behavior is precisely what the company needs to counter the perception that its revenue stream remains lumpy and project-dependent.

RfRecon Adds a Second-Half Catalyst

The product pipeline offers another potential lever. DroneShield unveiled RfRecon, a portable radio-frequency reconnaissance device, in early August and flagged strong interest from tier-1 end customers. First sales are expected in the second half of fiscal 2026, and if that early enthusiasm converts into purchase orders, the product could broaden the company's revenue base beyond its core drone-defense franchise.

The timing matters. DroneShield reported an adjusted EBITDA loss of A$12.4 million and a net loss of A$32.2 million for the first half, reflecting investments in production capacity and systems. The company is effectively spending ahead of the revenue curve, and the confirmed backlog provides the argument that those outlays will eventually meet a growing top line — provided the secured orders convert as planned.

Institutional Interest Meets a Wall of Shorts

The ownership picture adds another layer of complexity. Citigroup entities reported a stake above five percent in early August, following JPMorgan Chase's decision to increase its position days earlier — a move that briefly pushed the share price higher at the time. Yet according to the Australian Securities and Investments Commission, DroneShield was simultaneously among the most short-sold stocks on the Australian market.

That split positioning is unusual. Institutional buyers and short sellers are rarely this evenly matched on a single name, and the standoff suggests the market has yet to reach a consensus on where the company is headed. The high level of open short interest may also explain why positive news — including the bank stake-building — has failed to spark a sustained rally. Short sellers betting on further declines can generate persistent selling pressure as long as the fundamental picture remains ambiguous.

For investors, the near-term path is likely to stay volatile. The competing forces of large institutional accumulation and heavy short positioning could keep the shares swinging in both directions, regardless of how the operational story around record revenue and new products like RfRecon develops. What happens next will depend on whether the company can translate its growing backlog into the kind of consistent execution that forces one side of this trade to capitulate.